loading

Biocryst Pharmaceuticals Inc Azioni (BCRX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
155.06%
406.56
159.40 163.35 145.53 131.53
Cost Of Revenue
335.39%
9.522
2.187 2.798 4.568 6.094
Gross Profit
152.55%
397.03
157.21 160.56 140.97 125.44
Operating Expenses
7.08%
136.65
127.62 130.77 119.74 129.95
Benefits Costs and Expenses
7.65%
158.54
147.26 156.87 144.78 157.53
Costs And Expenses
12.61%
146.17
129.80 133.57 124.31 136.04
Operating Income/Loss
779.95%
260.38
29.59 29.79 21.23 -4.508
Nonoperating Income/Loss
29.17%
-12.37
-17.46 -23.30 -20.47 -
Income/Loss From Continuing Operations Before Tax
1,945%
248.02
12.13 6.486 0.758 -25.99
Income Tax Expense/Benefit
382.44%
2.172
-0.769 1.401 0.726 0.804
Income/Loss From Continuing Operations After Tax
1,806%
245.84
12.90 5.085 0.032 -26.80
Net Income/Loss
1,806%
245.84
12.90 5.085 0.032 -26.80
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.83%
0.362
210.18 209.52 208.88 0.23
Diluted Average Shares
99.89%
0.232
219.88 219.89 215.26 0.23
Basic Earnings Per Share
1,850%
1.17
0.06 0.02 - -0.13
Diluted Earnings Per Share
1,783%
1.13
0.06 0.02 - -0.13
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$22.94
price up icon 1.15%
drug_manufacturers_specialty_generic RGC
$23.23
price down icon 3.21%
drug_manufacturers_specialty_generic RDY
$14.13
price down icon 1.53%
$129.78
price up icon 1.57%
$13.51
price down icon 2.10%
$536.12
price up icon 0.62%
Capitalizzazione:     |  Volume (24 ore):